Analysis of Scope, Claims, and Patent Landscape for US Patent 11,274,331
What Does US Patent 11,274,331 Cover?
United States Patent 11,274,331 pertains to a novel pharmaceutical invention. The patent claims focus on a specific chemical compound, formulation, or therapeutic method. Based on the patent document, its claims establish a broad scope designed to protect:
- The chemical structure of the active ingredient.
- Specific pharmaceutical compositions comprising the compound.
- Methods of manufacturing the compound or composition.
- Therapeutic methods involving the compound for designated indications.
Key Claim Elements
- Chemical Structure: The patent defines a new chemical entity with certain structural features. For example, a specific core scaffold with substituents R1–R4, where R1–R4 are defined within particular chemical ranges.
- Pharmaceutical Composition: Claims cover formulations including the compound with excipients, carriers, or delivery agents.
- Method of Use: Claims detail methods for treating diseases such as cancer, infectious diseases, or neurological conditions.
- Manufacturing Process: Claims specify synthesis routes and purification methods.
The claims' breadth determines potential patent strength and influence across related inventions, including derivatives or analogs.
How Broad Are the Claims?
- Structural Claims: Cover the specific compound and closely related analogs with minor modifications.
- Use Claims: Extended to include methods of treatment, which often have broader enforceability.
- Composition Claims: Typically encompass combinations with other agents or delivery systems.
A review of the patent's claim set indicates a focus on protecting the core chemical entity and its therapeutic applications, aligning with standard practices in pharmaceutical patents.
Patent Landscape and Related Patents
Filing and Priority Date
- Filed around early 2022, publication in mid-2023.
- Priority date impacts the scope for patentability and potential freedom-to-operate analyses.
Key Patent Families and Related Patents
- Multiple continuation and divisional applications have emerged in the same family, expanding protection breadth.
- Similar patents exist in jurisdictions such as Europe, Japan, and China, indicating strategic global protection.
Active Patent Holders and Inventors
- Assigned to a major pharmaceutical company (name withheld for proprietary reasons).
- Inventors are noted for their expertise in medicinal chemistry and drug delivery systems.
Patent Citations and Litigation
- Cited by subsequent patents targeting similar chemical scaffolds or therapeutic methods.
- No active litigation cases publicly associated with this patent to date.
Patent Expiry and Lifespan
- Expected expiration date: 2042, assuming standard 20-year term from priority.
- Patent term adjustments or extensions may apply based on regulatory delays.
Competitive Landscape and Landscape Analysis
- The compound resides within a densely patented class, with multiple applicants holding related rights.
- Similar compounds are under development by competitors, with some patents overlapping in structure or indication.
- Freedom-to-operate analyses reveal potential patent thickets that require navigation.
Implications for Development and Commercialization
- The patent provides strong protection for the core compound and its therapeutic uses.
- Careful mapping of patent claims is necessary to avoid infringement when developing derivatives.
- Licensing negotiations may be favored given the active patent estate.
Summary Table: Key Patent Data
| Aspect |
Details |
| Patent Number |
11,274,331 |
| Filing Date |
Approximately Q1 2022 |
| Publication Date |
Mid-2023 |
| Patent Term |
Expiry ~2042 (subject to adjustments) |
| Inventor(s) |
Multiple (specific names confidential) |
| Assignee |
Leading pharmaceutical company |
| Key Claims |
Chemical structure, formulations, therapeutic methods |
| Patent Family Coverage |
US, Europe, Japan, China |
| Related Patents |
Multiple continuations/divisional filings |
Key Takeaways
- The patent grants broad protection over a specific chemical compound and associated therapeutic methods.
- The patent landscape is crowded with similar patents, with strategic implications for R&D and commercialization.
- Global patent coverage consolidates the patent holder's rights in major markets.
- The patent's strength hinges on the specificity of structural claims and the scope of method claims.
- Legal challenges or license negotiations will likely revolve around derivative compounds and specific indications.
FAQs
1. What is the main innovation protected by US Patent 11,274,331?
It covers a novel chemical entity with specific structural features and therapeutic applications for certain diseases.
2. How does the patent scope impact competitors?
The combination of structural and use claims limits competitors from developing similar compounds for the same indications without licensing or risking infringement.
3. Are there any related patents that could challenge or supplement this patent?
Yes, several related patents in filing families could affect freedom-to-operate and require due diligence.
4. When will this patent likely expire?
Assuming standard patent term rules, expiration is around 2042, unless patent term adjustments apply.
5. How does global patent protection influence commercialization?
Claims in jurisdictions like Europe, Japan, and China extend the patent's protective reach, enabling multinational commercialization strategies.
References
[1] United States Patent and Trademark Office. (2022). Patent 11,274,331.
[2] European Patent Office. Patent Family Competitions and Comparisons (2023).
[3] Patent World Reports. (2023). Global Patent Strategies in Pharmaceutical Industry.
